UNIQUE IN VIVO MODEL IN ONCOLOGY

Orateur : Jean VIALLET (Inovotion, Grenoble)

INOVOTION is a biotech company (spin-off of IAB Grenoble-Alpes-University) which developed a unique in vivo technology dedicated to efficacy and toxicity evaluations for anti-cancer treatments and target validation. This unique technology provides early analysis of drug candidates and targets, before the classical preclinical stage. By eliminating low-value molecules early, INOVOTION accelerates the drug discovery process, increases the R&D productivity and reduces its costs. INOVOTION built this model using chick embryo because it has several advantages : fast, sensitive, reliable and affordable. These in vivo assays will save time and give a clear competitive advantage to public and private researchers. We have standardized our tests for 40 classical standard cell lines and are calibrating the technology for a new cell line approximately every month. We have also calibrated our tests for several tens of our clients’ modified cell lines, PDX and patient’s Biopsies. We have standardized all type of refence compounds including classic small molecule but also antibody, ADC like Herceptin and Kadcyla and Immuno-oncology molecules.

Télécharger dans mon agenda